ViciniVax BV
PrivateLast Round
VC Round
Jul 1, 2026
Company Overview
ViciniVax BV is a clinical-stage biopharmaceutical company that develops therapeutic cancer vaccines for the treatment of HPV-related premalignant lesions and cervical cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViciniVax BV Comparables
Compare ViciniVax BV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Barinthus Biotherapeutics | 78% | |
| PDS Biotechnology Corp | 78% | |
| Nykode Therapeutics | 77% |
ViciniVax BV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 1, 2026 |
ViciniVax BV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RuG Ventures | Seed |
| Hanzepoort B.V. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Monthly visitors increased 135% MoM, reaching 2.1K.
ViciniVax BV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ViciniVax BV's valuation, stock price, and market status.
Is ViciniVax BV a public or private company?
ViciniVax BV is a private company.
What is the current stock price of ViciniVax BV?
ViciniVax BV is a private company with no public stock price. No recent secondary market data is available.
How much is ViciniVax BV worth (valuation)?
Valuation information for ViciniVax BV is not publicly available.
Can I buy ViciniVax BV stock?
ViciniVax BV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ViciniVax BV's last funding round?
ViciniVax BV's most recent funding round was VC Round on July 1, 2026.
Who are the main investors in ViciniVax BV?
Key investors in ViciniVax BV include RuG Ventures, Hanzepoort B.V..
Will ViciniVax BV IPO soon?
No public IPO plans have been announced for ViciniVax BV.
How can I track ViciniVax BV secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ViciniVax BV's secondary market activity and sign up for updates.